Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
specificStage IIA includes: T1-2, N1-2, M0, B0-1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopa
7
Centers
7
Active Trials
—
Cancer Funding
Top Centers for Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive High-Volume Research Center | 76.4 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 57.1 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 57.1 |
| 4 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 57.1 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 57.1 |
| 6 | Boston University Cancer CenterBoston, MA Active Research Program | 57.1 |
| 7 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 37.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →